Why is Matrix-Bios metabolite profiling such as powerful tool for breast cancer detection?
When breast cancer is diagnosed in its early stages, the patient has more treatment options and chances of survival are higher. Matrix-Bio’s metabolite profiling-based blood test is extremely accurate as it identifies and quantifies small molecule biomarkers in the blood that indicate breast cancer even in its earliest stages. This is an exciting, potentially life-saving advancement as breast cancer tumors can grow for six to eight years before being detected by mammography.
Related Questions
- Over the last ten years the incidence of breast cancer has doubled. Is it not incumbent upon us to use every proven diagnostic tool available for the earliest detection of breast disease?
- Does Matrix-Bios metabolite profiling technology platform have other disease applications?
- How is Matrix-Bio using metabolite profiling for breast cancer?
